MARKER THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 15th, 2019 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 15th, 2019 Company Industry JurisdictionThis Consulting Services Agreement (“Agreement”) is hereby made and entered into this 19th day of October, 2018 (“Effective Date”) by and between Marker Therapeutics, Inc., a Delaware corporation, having an address at 3200 Southwest Freeway, Suite 2240, Houston, Texas 77027 and its subsidiaries (“Marker” or the “Company”), and Ann Leen, having an address at 2727 Drexel Drive, Houston, Texas 77027 (“Consultant”). Marker and Consultant are referred to herein collectively as the “Parties” and individually as a “Party.”
MARKER THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENTConsulting Services Agreement • October 23rd, 2018 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledOctober 23rd, 2018 Company Industry JurisdictionThis Consulting Services Agreement (“Agreement”) is hereby made and entered into this 19th day of October, 2018 (“Effective Date”) by and between Marker Therapeutics, Inc., a Delaware corporation, having an address at 3200 Southwest Freeway, Suite 2240, Houston, Texas 77027 and its subsidiaries (“Marker” or the “Company”), and Juan F. Vera, having an address at 2727 Drexel Drive, Houston, Texas 77027 (“Consultant”). Marker and Consultant are referred to herein collectively as the “Parties” and individually as a “Party.”